Core Insights - Zoetis Inc. is a leading global animal health company that develops, manufactures, and markets veterinary vaccines and medicines, serving veterinarians, livestock producers, and pet owners [1] - KeyBanc initiated coverage of Zoetis with a "Sector Weight" rating, indicating expectations for the company's performance to align with the broader sector [2][5] - The stock price of Zoetis has fluctuated significantly, with a year high of $181.85 and a low of $115.25, reflecting its substantial market presence with a market capitalization of approximately $51.07 billion [4][5] Company Participation - Zoetis is scheduled to participate in the Piper Sandler 37th Annual Healthcare Conference on December 4, 2025, with CEO Kristin Peck and CFO Wetteny Joseph representing the company [3][5] - The conference will provide insights into the company's strategies and performance, with a live audio webcast available for investors [3] Stock Performance - The stock price of Zoetis was $115.89 when KeyBanc initiated coverage, reflecting a decrease of 1.02% or $1.19 on that day [2] - During the trading day, the stock price fluctuated between $115.80 and $118.43, with a trading volume of 3,260,584 shares [4]